Philadelphia, Pennsylvania, USA
June 17, 2015

BIO’s new Board Chair, Ron Cohen, CEO of Acorda Therapeutics, announced during Wednesday afternoon’s Keynote Luncheon of the 2015 BIO International Convention that the Biotechnology Industry Organization would soon become the Biotechnology Innovation Organization.

Cohen, in his first remarks as BIO’s new Board Chair, said, “I’m pleased to announce that the BIO Board has approved a change to BIO’s name… from the Biotechnology Industry Organization to the Biotechnology Innovation Organization. Still BIO, but now with a name that better expresses the essence of what our member companies represent.”

The new name will be launched in early 2016.

BIO’s President and CEO, Jim Greenwood added, "This is a great move that will help clarify for policymakers and the public the heart of our industry - scientific innovation that will help to heal, feed and fuel the world.  Each day, our members use cutting edge science and technology to deliver game-changing products, therapies and cures to improve the human condition.”

Website: http://www.bio.org

Published: June 18, 2015